Oncocross strives to develop treatments for intractable and rare diseases with their transcriptome data-based AI platforms and drug discovery pipelines. Oncocross’s main proprietary AI platforms are RAPTOR AI™ for drug development, and ONCO-RAPTOR AI™ for the identification of optimal indications of anticancer drugs and companion diagnostic biomarkers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2015
- Website
- www.oncocross.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Oncocross (온코크로스)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now